CN103119435A - 用于检测饮料中的药物的方法和试剂 - Google Patents

用于检测饮料中的药物的方法和试剂 Download PDF

Info

Publication number
CN103119435A
CN103119435A CN2011800334204A CN201180033420A CN103119435A CN 103119435 A CN103119435 A CN 103119435A CN 2011800334204 A CN2011800334204 A CN 2011800334204A CN 201180033420 A CN201180033420 A CN 201180033420A CN 103119435 A CN103119435 A CN 103119435A
Authority
CN
China
Prior art keywords
medicament
green
fcf
particles
preventing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011800334204A
Other languages
English (en)
Chinese (zh)
Inventor
C·埃里
P·孔塔曼
E·迪波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethypharm SAS
Original Assignee
Ethypharm SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm SAS filed Critical Ethypharm SAS
Publication of CN103119435A publication Critical patent/CN103119435A/zh
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01D—MEASURING NOT SPECIALLY ADAPTED FOR A SPECIFIC VARIABLE; ARRANGEMENTS FOR MEASURING TWO OR MORE VARIABLES NOT COVERED IN A SINGLE OTHER SUBCLASS; TARIFF METERING APPARATUS; MEASURING OR TESTING NOT OTHERWISE PROVIDED FOR
    • G01D7/00—Indicating measured values
    • G01D7/005—Indication of measured value by colour change
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
    • G01N31/22—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Pathology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN2011800334204A 2010-07-06 2011-07-05 用于检测饮料中的药物的方法和试剂 Pending CN103119435A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1055490A FR2962550B1 (fr) 2010-07-06 2010-07-06 Methode pour lutter contre la soumission chimique, utilisation d'agent colorant pour lutter contre la soumission chimique et composition pharmaceutique permettant la mise en oeuvre de la methode
FR1055490 2010-07-06
PCT/FR2011/051600 WO2012010765A1 (fr) 2010-07-06 2011-07-05 Methode et agent pour la detection de drogues dans les boisson

Publications (1)

Publication Number Publication Date
CN103119435A true CN103119435A (zh) 2013-05-22

Family

ID=43587415

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011800334204A Pending CN103119435A (zh) 2010-07-06 2011-07-05 用于检测饮料中的药物的方法和试剂

Country Status (13)

Country Link
US (1) US20130098286A1 (enExample)
EP (1) EP2591350B1 (enExample)
JP (1) JP5916723B2 (enExample)
KR (2) KR20130091321A (enExample)
CN (1) CN103119435A (enExample)
AU (1) AU2011281482B2 (enExample)
CA (1) CA2802402A1 (enExample)
ES (1) ES2609831T3 (enExample)
FR (1) FR2962550B1 (enExample)
IL (1) IL223886B (enExample)
MX (1) MX344783B (enExample)
WO (1) WO2012010765A1 (enExample)
ZA (1) ZA201300099B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104237224A (zh) * 2014-10-14 2014-12-24 厦门奥亚仪器有限公司 苯二氮卓的快速检测方法及其操作器皿组合

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220202742A1 (en) * 2019-05-07 2022-06-30 Clexio Biosciences Ltd. Dosage forms for preventing drug-facilitated assault
US20220175719A1 (en) * 2020-10-24 2022-06-09 Mason Cave Dissolvable thc beverage tablet production method
US20220241238A1 (en) * 2020-10-24 2022-08-04 Michael Roth Method for forming a beverage with a dissolvable thc tablet
CN115112582B (zh) * 2022-05-19 2024-08-09 西南科技大学 一种去甲芬太尼及芬太尼的检测试剂盒及其检测方法
CN117654708A (zh) * 2023-10-16 2024-03-08 杭州德望纳米科技有限公司 一种基于球磨实验改变蛇纹石粒度分级方法

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1157662A (en) * 1966-08-08 1969-07-09 Codex S A Improvements in or relating to Pharmaceutical Compositions
EP0923934A1 (en) * 1997-12-17 1999-06-23 Ranbaxy Laboratories, Ltd. Modified release matrix formulation of cefaclor and cephalexin
WO2001058424A1 (en) * 2000-02-09 2001-08-16 West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited Floating drug delivery composition
EP1273301A2 (en) * 2001-07-06 2003-01-08 Altergon S.A. Pharmaceutical preparations based on active ingredients susceptible to illicit administration
US20030044989A1 (en) * 2001-09-04 2003-03-06 Guerra Francisco Javier Apparatus and method for testing a beverage for a clandestine illicit substance
CN1437462A (zh) * 2000-04-20 2003-08-20 爱的发 泡腾颗粒及其制造方法
US6617123B1 (en) * 2000-06-29 2003-09-09 Jack V. Smith Method for detection of 4-hydroxybutyric acid and its precursor(s) in fluids
WO2008033351A2 (en) * 2006-09-11 2008-03-20 Theraquest Biosciences, Inc. Multimodal abuse resistant and extended release formulations

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2679451B1 (fr) 1991-07-22 1994-09-09 Prographarm Laboratoires Comprime multiparticulaire a delitement rapide.
FR2766089B1 (fr) 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
FR2785538B1 (fr) 1998-11-06 2004-04-09 Prographarm Laboratoires Comprime a delitement rapide perfectionne
EP1005863A1 (en) * 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
FR2787715B1 (fr) * 1998-12-23 2002-05-10 Synthelabo Composition pharmaceutique comprenant un compose hypnotique ou un de ses sels pharmaceutiquement acceptables
FR2790387B1 (fr) 1999-03-01 2001-05-18 Prographarm Laboratoires Comprime orodispersible presentant une faible friabilite et son procede de preparation
FR2829933B3 (fr) * 2001-09-21 2004-03-12 Ellipse Pharmaceuticals Procede de fabrication d'un produit pharmaceutique administrable par voie orale avec des agents detrompeurs notamment de gout et produit obtenu
FR2829932B1 (fr) * 2001-09-21 2006-11-24 Ellipse Pharmaceuticals Procede de fabrication d'un produit pharmaceutique administrable par voie orale avec des agents detrompeurs et produit obtenu
FR2831820B1 (fr) 2001-11-05 2004-08-20 Ethypharm Sa Comprime orodispersible presentant une grande homogeneite et son procede de preparation
EP1714145A1 (en) 2003-12-19 2006-10-25 Bloomsbury Innovations Ltd. Apparatus for detecting drugs in a beverage
JP2009256295A (ja) * 2008-04-11 2009-11-05 Kosumedei Seiyaku Kk 化粧用粘着シート
JP5059678B2 (ja) * 2008-04-18 2012-10-24 エーザイ・アール・アンド・ディー・マネジメント株式会社 着色固形製剤およびその製造方法
FR2962331B1 (fr) * 2010-07-06 2020-04-24 Ethypharm Forme pharmaceutique pour lutter contre la soumission chimique, methode la mettant en oeuvre

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1157662A (en) * 1966-08-08 1969-07-09 Codex S A Improvements in or relating to Pharmaceutical Compositions
EP0923934A1 (en) * 1997-12-17 1999-06-23 Ranbaxy Laboratories, Ltd. Modified release matrix formulation of cefaclor and cephalexin
WO2001058424A1 (en) * 2000-02-09 2001-08-16 West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited Floating drug delivery composition
CN1437462A (zh) * 2000-04-20 2003-08-20 爱的发 泡腾颗粒及其制造方法
US6617123B1 (en) * 2000-06-29 2003-09-09 Jack V. Smith Method for detection of 4-hydroxybutyric acid and its precursor(s) in fluids
EP1273301A2 (en) * 2001-07-06 2003-01-08 Altergon S.A. Pharmaceutical preparations based on active ingredients susceptible to illicit administration
US20030044989A1 (en) * 2001-09-04 2003-03-06 Guerra Francisco Javier Apparatus and method for testing a beverage for a clandestine illicit substance
WO2008033351A2 (en) * 2006-09-11 2008-03-20 Theraquest Biosciences, Inc. Multimodal abuse resistant and extended release formulations

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104237224A (zh) * 2014-10-14 2014-12-24 厦门奥亚仪器有限公司 苯二氮卓的快速检测方法及其操作器皿组合

Also Published As

Publication number Publication date
FR2962550A1 (fr) 2012-01-13
KR20130091321A (ko) 2013-08-16
KR20180080374A (ko) 2018-07-11
ZA201300099B (en) 2014-03-26
JP2013530206A (ja) 2013-07-25
MX344783B (es) 2017-01-06
JP5916723B2 (ja) 2016-05-11
CA2802402A1 (fr) 2012-01-26
US20130098286A1 (en) 2013-04-25
ES2609831T3 (es) 2017-04-24
MX2012015103A (es) 2013-05-28
AU2011281482A1 (en) 2013-01-17
IL223886B (en) 2018-03-29
FR2962550B1 (fr) 2013-06-14
EP2591350B1 (fr) 2016-10-26
WO2012010765A1 (fr) 2012-01-26
AU2011281482B2 (en) 2015-10-01
EP2591350A1 (fr) 2013-05-15
KR101957657B1 (ko) 2019-03-12

Similar Documents

Publication Publication Date Title
EP1194132B1 (en) Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
WO2006055142A2 (en) Taste-masked multiparticulate pharmaceutical compositions comprising a drug-containing core particle and a solvent-coacervated membrane
KR101957657B1 (ko) 음료 내의 약물을 검출하기 위한 방법 및 성분
CN103118667B (zh) 用于打击药物化学呈递的药物形式
JP5960158B2 (ja) ゾルピデムベースの口腔内崩壊医薬錠剤
EP2651391B1 (en) Pharmaceutical composition for oral administration intended to prevent misuse
HK1184050B (en) Pharmaceutical form for combating chemical submission of a medicament
HK1184219A (zh) 用於检测饮料中的药物的方法和试剂

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1184219

Country of ref document: HK

RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20130522

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1184219

Country of ref document: HK